NCT07446634

Brief Summary

This study looks at how jaw surgery called maxillomandibular advancement with counterclockwise rotation affects breathing during sleep in people with moderate to severe obstructive sleep apnea who cannot tolerate standard treatments such as Continous Positive Airway pressure treatment. The participants are followed over time to see whether the surgery improves sleep apnea symptoms, daytime sleepiness, and airway size, and whether these improvements last. Advanced three-dimensional imaging and airflow analysis are used to better understand how the surgery changes the airway and breathing. The goal is to evaluate the long-term effectiveness and safety of this surgical treatment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
74mo left

Started Feb 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Feb 2014Jun 2032

Study Start

First participant enrolled

February 6, 2014

Completed
12 years until next milestone

First Submitted

Initial submission to the registry

February 11, 2026

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 3, 2026

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2031

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2032

Last Updated

March 3, 2026

Status Verified

February 1, 2026

Enrollment Period

17.4 years

First QC Date

February 11, 2026

Last Update Submit

February 25, 2026

Conditions

Keywords

Sleep ApneaOrthognathic Surgical ProcedureTomographyComputational Fluid Dynamics

Outcome Measures

Primary Outcomes (1)

  • Apnea Hypopnea Index (AHI/h)

    Change in AHI/h. Lower value means better outcome, value \< 5 is considered healthy.

    Registration presurgically and at 3 months, 2 years and 5 years post operatively

Secondary Outcomes (7)

  • Upper airway volume

    Registration presurgically and at 3 months, 2 years and 5 years post operatively

  • Airway velocity

    Registration presurgically and at 3 months, 2 years and at 5 years post operatively.

  • Epworth Sleepiness Scale (ESS)

    Registration presurgically and at 3 months, 2 years and 5 years post operatively

  • Blood pressure

    Registration presurgically and at 3 months, 2 years and 5 years post operatively

  • Quality of Life (QoL), Short Form-36 Health Survey

    Registration presurgically and at 3 months, 2 years and 5 years post operatively

  • +2 more secondary outcomes

Study Arms (1)

Intervention

EXPERIMENTAL

Single arm study with counterclockwise rotational maxillo-mandibular advancement surgery

Procedure: Maxillomandibular advancement surgery with counterclockwise rotation

Interventions

Maxillary advancement by LeFort I osteotomy and mandibular advancement by bilateral sagittal split osteotomy

Intervention

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of obstructive sleep apnea with AHI ≥15 events/h.
  • Residence and/or registration in Dalarna County
  • Body mass index (BMI; kg/m\^2) between 15 and 35
  • Documented failure of CPAP or mandibular advancement therapy.

You may not qualify if:

  • Medical conditions contraindicating general anesthesia.
  • American Society of Anesthesiologists Physical Status (ASA) Class III-VI
  • Central sleep apnea
  • Narcolepsy
  • Prior orthognathic surgery
  • History of tumor disease or radiotherapy of the jaws. Participants with systemic conditions associated with an increased risk of OSA. Such risks include;
  • Hypothyroidism
  • Acromegaly
  • Diabetes mellitus
  • Active generalized rheumatoid arthritis
  • Clinically manifest periodic limb movement disorder
  • Restless legs syndrome.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Falu Hospital

Falun, Dalarna County, 79182, Sweden

RECRUITING

MeSH Terms

Conditions

Sleep Apnea, ObstructiveSleep Apnea Syndromes

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Andreas Thor, Professor

    Department of Surgical Sciences, Oral and Maxillofacial Surgery, Uppsala University, Uppsala, Sweden.

    STUDY CHAIR

Central Study Contacts

Jani M A Talvilahti, DDS, Head

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Prospective singel center study
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Head of Maxillofacial Surgery, DDS

Study Record Dates

First Submitted

February 11, 2026

First Posted

March 3, 2026

Study Start

February 6, 2014

Primary Completion (Estimated)

June 30, 2031

Study Completion (Estimated)

June 30, 2032

Last Updated

March 3, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations